Perfil
Tjeerd Barf is the founder of Artica Therapeutics BV, founded in 2020, holding the title of Chief Executive Officer & Executive Director.
Dr. Barf is also the founder of Acerta Pharma BV..
Dr. Barf currently holds the position of Director at Cytura Therapeutics BV since 2019.
Dr. Barf completed graduate and doctorate degrees at the University of Groningen.
Cargos activos de Tjeerd Barf
| Empresas | Cargo | Inicio |
|---|---|---|
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Director/Miembro de la Junta | 01/04/2019 |
Artica Therapeutics BV
Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops covalent therapeutics for autoimmune and inflammatory disorders | Fundador | 01/01/2020 |
Antiguos cargos conocidos de Tjeerd Barf.
| Empresas | Cargo | Fin |
|---|---|---|
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Fundador | 01/03/2020 |
Formación de Tjeerd Barf.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Artica Therapeutics BV
Artica Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops covalent therapeutics for autoimmune and inflammatory disorders | Health Technology |
- Bolsa de valores
- Insiders
- Tjeerd Barf
















